Determinants of and pharmacologic modulation of acute toxicity associated with systemic administration of first generation and helper-dependent adenoviral vectors

被引：0
|
作者：
Toietta, G
Mane, VP
Pastore, L
Finegold, MJ
Ng, P
Beaudet, AL
Lee, B
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Naples, Italy
[3] Univ Naples Federico II, CEINGE Biotecnol Avanzate, Naples, Italy
[4] Baylor Coll Med, Houston, TX 77030 USA
[5] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA
来源：
MOLECULAR THERAPY | 2003年 / 7卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
410
引用
收藏
页码：S162 / S162
页数：1
相关论文
共 30 条
  • [1] Modulation of TNFα, a determinant of acute toxicity associated with systemic delivery of first-generation and helper-dependent adenoviral vectors
    Mane, V. P.
    Toietta, G.
    McCormack, W. M.
    Conde, I.
    Clarke, C.
    Palmer, D.
    Finegold, M. J.
    Pastore, L.
    Ng, P.
    Lopez, J.
    Lee, B.
    [J]. GENE THERAPY, 2006, 13 (17) : 1272 - 1280
  • [2] Modulation of TNFα, a determinant of acute toxicity associated with systemic delivery of first-generation and helper-dependent adenoviral vectors
    V P Mane
    G Toietta
    W M McCormack
    I Conde
    C Clarke
    D Palmer
    M J Finegold
    L Pastore
    P Ng
    J Lopez
    B Lee
    [J]. Gene Therapy, 2006, 13 : 1272 - 1280
  • [3] Generation of helper-dependent adenoviral vectors by homologous recombination
    Toietta, G
    Pastore, L
    Cerullo, V
    Finegold, M
    Beaudet, AL
    Lee, B
    [J]. MOLECULAR THERAPY, 2002, 5 (02) : 204 - 210
  • [4] Acute toxicity following high dose systemic delivery of helper-dependent adenoviral vectors into nonhuman primates
    Ng, P
    Brunetti-Pierri, N
    Palmer, D
    Carey, D
    Finegold, M
    Beaudet, A
    [J]. MOLECULAR THERAPY, 2003, 7 (05) : S456 - S457
  • [5] Toxicity Associated with Repeated Administration of First-Generation Adenovirus Vectors Does Not Occur with a Helper-Dependent Vector
    Wanda K. O’Neal
    Heshan Zhou
    Núria Morral
    Claire Langston
    Robin J. Parks
    Frank L. Graham
    Stefan Kochanek
    Arthur L. Beaudet
    [J]. Molecular Medicine, 2000, 6 : 179 - 195
  • [6] Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector
    O'Neal, VK
    Zhou, HS
    Morral, N
    Langston, C
    Parks, RJ
    Graham, FL
    Kochanek, S
    Beaudet, AL
    [J]. MOLECULAR MEDICINE, 2000, 6 (03) : 179 - 195
  • [7] Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates
    Brunetti-Pierri, N
    Palmer, DJ
    Beaudet, AL
    Carey, KD
    Finegold, M
    Ng, P
    [J]. HUMAN GENE THERAPY, 2004, 15 (01) : 35 - 46
  • [8] Toxicity and adaptive immune response to intracellular transgenes delivered by helper-dependent vs. first generation adenoviral vectors
    Mian, A
    Guenther, M
    Finegold, M
    Ng, P
    Rodgers, J
    Lee, B
    [J]. MOLECULAR GENETICS AND METABOLISM, 2005, 84 (03) : 278 - 288
  • [9] Helper-Dependent Adenoviral Vectors Induce Less Intimal Growth than First-Generation Adenoviral Vectors in Arteries of Hypercholesterolemic Rabbits
    Jiang, Bo
    Qian, Kun
    Du, Liang
    Luttrell, Ian
    Chitaley, Kanchan
    Dichek, David
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E96 - E96
  • [10] Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration
    Parks, RJ
    Evelegh, CM
    Graham, FL
    [J]. GENE THERAPY, 1999, 6 (09) : 1565 - 1573
123